Role of the rate of internalization of the agonist-receptor complex on the agonist-induced down-regulation of the lutropin/choriogonadotropin receptor

Molecular Endocrinology

Volumn 13, Issue 8, 1999, Pages 1295-1304

  Nakamura, K ^a   Lazari, Md F M ^a   Li, S ^a   Korgaonkar, C ^a   Ascoli, M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CHORIONIC GONADOTROPIN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LUTEINIZING HORMONE RECEPTOR; MUTANT PROTEIN; PROTEIN KINASE; RETINA S ANTIGEN;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE MUTATION; GENETIC TRANSFECTION; HALF LIFE TIME; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033304965     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.8.0331     Document Type: Article

References (42)

1. Lysosomal accumulation of the hormone-receptor complex during receptor-mediated endocytosis of human choriogonadotropin
2. Pathways of internalization of the hCG/LH receptor: Immunoelectron microscopic studies in Leydig cells and transfected L cells
3. Phosphorylation of the lutropin/choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone
4. Mutation of individual serine residues in the C-terminal tail of the lutropin/ choriogonadotropin (LH/CG) receptor reveal distinct structural requirements for agonist-induced uncoupling and agonist-induced internalization
5. The role of receptor kinases and arrestins in G protein-coupled receptor regulation
6. On the mechanisms involved in the regulation of the cell surface receptors for human choriogonadotropin and mouse epidermal growth factor in cultured Leydig tumor cells
7. Mutations that induce constitutive activation and mutations that impair signal transduction modulate the basal and/or agonist-stimulated internalization of the lutropin/choriogonadotropin receptor
8. The slow rate of internalization of deglycosylated hCG is not due to its inability to stimulate cAMP accumulation
9. Two mutations of the lutropin/choriogonadotropin receptor that impair signal transduction also interfere with receptor-mediated endocytosis
10. Endocytosis
11. Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits
12. Lutropin/choriogo-nadotropin down-regulates its receptor by both receptor mediated endocytosis and a cAMP-dependent reduction in receptor mRNA
13. Effects of truncations of the cytoplasmic tail of the lutropin/choriogonadotropin receptor on receptor-mediated hormone internalization
14. Progressive cytoplasmic tail truncations of the lutropin-choriogonadotropin receptor prevent agonist- or phorbol ester-induced phosphorylation, impair agonist- or phorbol ester-induced desensitization and enhance agonist-induced receptor down-regulation
15. Down-regulation of gonadotropin receptors in a murine Leydig tumor cell line
16. Palmitoylation of luteinizing hormone/human choriogonadotropin receptors in transfected cells
17. A serine cluster prevents recycling of the V2 vasopressin receptor
18. 2 receptors: Evidence for selective sorting of receptor and ligand
19. Transfected cells express mostly the intracellular precursor of the lutropin/ choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity
20. 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor
21. A unique constitutively activating mutation in third transmbembrane helix of luteinizing hormone receptor causes sporadic male gonadotropin-independent precocious puberty
22. G protein-coupled receptors. III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization
23. Role of G protein-coupled receptor kinases on the agonist-induced phosphorylation, and internalization of the follitropin receptor
24. 2-adrenergic receptor sequestration: Intracellular complement of β-adrenergic receptor kinase and β-arrestin determine kinetics of internalization
25. Caron M.G. 1995 Role of phosphorylation in agonist-promoted β2-adrenergic receptor sequestration
26. On the fates of receptor-bound human ovine luteinizing hormone and human choriogonadotropin in cultured Leydig tumor cells. Demonstration of similar rates of internalization
27. Epidermal growth factor, a phorbol ester and cAMP decrease the transcription of the LH/CG receptor gene in MA-10 Leydig tumor cells
28. Characterization of the functional properties and nuclear binding proteins of the rat luteinizing hormone/chorionic gonadotropin receptor promoter in Leydig cells
29. Truncation of the cytoplasmic tail of the lutropin choriogonadotropin receptor prevents agonist-induced uncoupling
30. Lutropin-choriogonadotropin receptor: An unusual member of the G protein-coupled receptor family
31. Modulation of the arrestin-clathrin interaction in cells
32. β-Adrenergic receptor kinase: Primary structure delineates a multigene family
33. High-efficiency transformation of mammalian cells by plasmid DNA
34. Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal and activation- and phosphorylation-independent but arrestin-dependent pathway for internalization
35. Characterization of several clonal lines of cultured Leydig tumor cells: Gonadotropin receptors and steroidogenic responses
36. Studies on interstitial cells in tissue culture. II. Steroid biosynthesis by a clonal line of rat testicular interstitial cells
37. A steady state model for analyzing the cellular binding, internalization and degradation of polypeptide ligands
38. The endocytotic rate constant. A cellular parameter for quantitating receptor-mediated endocytosis
39. A polyclonal antibody to a synthetic peptide derived from the rat FSH receptor reveals the recombinant receptor as a 74 kDa protein
40. Differentially regulated expression of the G protein-coupled receptor kinases, βARK and GRK6, during myelomonocytic cell development in vitro
41. S-antigen: Preparation and characterization of site-specific monoclonal antibodies
42. Gonadotropin binding and stimulation of steroidogenesis in Leydig tumor cells